Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

1997

Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res. 1997;57(7):1259-63.

1996

Chilosi M, Doglioni C, Magalini A, Inghirami G, Krampera M, Nadali G, et al. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood. 1996;88(10):4012-20.

DelSal G, Loda M, Pagano M. Cell cycle and cancer: critical events at the G1 restriction point. Crit Rev Oncog. 1996;7(1-2):127-42.

Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 1996;149(1):273-82.

Schattner EJ, Mascarenhas J, Bishop J, Yoo DH, Chadburn A, Crow MK, et al. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood. 1996;88(4):1375-82.

Lin J, Chavin KD, Qin L, Ding Y, Bromberg JS. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3. Cell Immunol. 1996;167(2):249-58.

Husain AN, Siddiqui MT, Montoya A, Chandrasekhar AJ, Garrity ER. Post-lung transplant biopsies: an 8-year Loyola experience. Mod Pathol. 1996;9(2):126-32.

Ma ZW, Ward R, Hoda SA. Intraosseous malignant peripheral nerve sheath tumor. Arch Pathol Lab Med. 1996;120(6):517-8.

Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 1996;56(11):2556-60.

Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, et al. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Transplantation. 1996;62(7):1011-8.